Hofman, P. and Ilie, M. and Chamorey, E. and Brest, P. and Schiappa, R. and Nakache, V and Antoine, M. and Barberis, M. and Begueret, H. and Bibeau, F. and Bonnetaud, C. and Bostroem, P. and Brousset, P. and Bubendorf, L. and Carvalho, L. and Cathomas, G. and Cazes, A. and Chalabreysse, L. and Chenard, M-P and Copin, M-C and Cote, J-F and Damotte, D. and de Leval, L. and Delongova, P. and de Montpreville, V. Thomas and de Muret, A. and Dema, A. and Dietmaier, W. and Evert, M. and Fabre, A. and Forest, F. and Foulet, A. and Garcia, S. and Garcia-Martos, M. and Gibault, L. and Gorkiewicz, G. and Jonigk, D. and Gosney, J. and Hofman, A. and Kern, I and Kerr, K. and Kossai, M. and Kriegsmann, M. and Lassalle, S. and Long-Mira, E. and Lupo, A. and Mamilos, A. and Matej, R. and Meilleroux, J. and Ortiz-Villalon, C. and Panico, L. and Panizo, A. and Papotti, M. and Pauwels, P. and Pelosi, G. and Penault-Llorca, F. and Pop, O. and Pote, N. and Cajal, S. R. Y. and Sabourin, J-C and Salmon, I and Sajin, M. and Savic-Prince, S. and Schildhaus, H-U and Schirmacher, P. and Serre, I and Shaw, E. and Sizaret, D. and Stenzinger, A. and Stojsic, J. and Thunnissen, E. and Timens, W. and Troncone, G. and Werlein, C. and Wolff, H. and Berthet, J-P and Benzaquen, J. and Marquette, C-H and Hofman, V and Calabrese, F. (2021) Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future. ESMO OPEN, 6 (1): 100024. ISSN , 2059-7029
Full text not available from this repository. (Request a copy)Abstract
Background: This study evaluated the consequences in Europe of the COVID-19 outbreak on pathology laboratories orientated toward the diagnosis of thoracic diseases. Materials and methods: A survey was sent to 71 pathology laboratories from 21 European countries. The questionnaire requested information concerning the organization of biosafety, the clinical and molecular pathology, the biobanking, the workload, the associated research into COVID-19, and the organization of education and training during the COVID-19 crisis, from 15 March to 31 May 2020, compared with the same period in 2019. Results: Questionnaires were returned from 53/71 (75%) laboratories from 18 European countries. The biosafety procedures were heterogeneous. The workload in clinical and molecular pathology decreased dramatically by 31% (range, 3%-55%) and 26% (range, 7%-62%), respectively. According to the professional category, between 28% and 41% of the staff members were not present in the laboratories but did teleworking. A total of 70% of the laboratories developed virtual meetings for the training of residents and junior pathologists. During the period of study, none of the staff members with confirmed COVID-19 became infected as a result of handling samples. Conclusions: The COVID-19 pandemic has had a strong impact on most of the European pathology laboratories included in this study. Urgent implementation of several changes to the organization of most of these laboratories, notably to better harmonize biosafety procedures, was noted at the onset of the pandemic and maintained in the event of a new wave of infection occurring in Europe.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | DELAYS; UK; COVID-19; pathology; biosafety; lung cancer; activity |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Pathologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 04 Oct 2022 10:12 |
| Last Modified: | 04 Oct 2022 10:12 |
| URI: | https://pred.uni-regensburg.de/id/eprint/48231 |
Actions (login required)
 |
View Item |
